Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.13% |
| 2 | Technology | 2.97% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.09% |
| 5 | Industrials | 1.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EXAS
1651
CALL
DELISTED
Exact Sciences
EXAS
| $32.4M | 0.01% |
577,500
+81,400
| +16% | +$5.07M |
|
|
KLC
1652
KinderCare Learning Companies
KLC
$314M
| $32.4M | 0.01% |
+1,822,970
| New | +$43.7M |
|
1653
PUT
L3Harris
LHX
$54.4B
| $32.4M | 0.01% |
154,100
-11,900
| -7% | -$2.85M |
|
1654
CALL
ProShares Ultra VIX Short-Term Futures ETF
UVXY
$273M
| $32.4M | 0.01% |
312,530
+139,198
| +80% | +$16.4M |
|
|
FL
1655
PUT
DELISTED
Foot Locker
FL
| $32.4M | 0.01% |
1,486,700
+224,400
| +18% | +$5.24M |
|
1656
CALL
Futu Holdings
FUTU
$14.7B
| $32.3M | 0.01% |
404,100
-51,000
| -11% | -$4.77M |
|
1657
CALL
Cardinal Health
CAH
$54.1B
| $32.3M | 0.01% |
272,900
-128,400
| -32% | -$15M |
|
1658
Idexx Laboratories
IDXX
$43.4B
| $32.3M | 0.01% |
78,054
+54,954
| +238% | +$24.1M |
|
1659
Xcel Energy
XEL
$49.4B
| $32.2M | 0.01% |
476,488
+476,487
| +47,648,700% | +$32M |
|
1660
PUT
Match Group
MTCH
$8.69B
| $32.2M | 0.01% |
983,500
+591,400
| +151% | +$20.3M |
|
1661
Paychex
PAYX
$43.5B
| $32.1M | 0.01% |
229,115
+201,232
| +722% | +$28.6M |
|
1662
PUT
S&P Global
SPGI
$124B
| $32.1M | 0.01% |
64,500
-29,200
| -31% | -$14.8M |
|
1663
PUT
Nutrien
NTR
$32.5B
| $32.1M | 0.01% |
717,600
-193,000
| -21% | -$9.16M |
|
1664
Moderna
MRNA
$25.3B
| $32.1M | 0.01% |
771,892
+519,516
| +206% | +$24.8M |
|
1665
Dentsply Sirona
XRAY
$2.33B
| $32M | 0.01% |
1,685,817
+441,333
| +35% | +$9.33M |
|
|
1666
Futu Holdings
FUTU
$14.7B
| $32M | 0.01% |
399,657
+238,363
| +148% | +$22.3M |
|
1667
PUT
WIX.com
WIX
$3.13B
| $32M | 0.01% |
149,000
-31,100
| -17% | -$5.94M |
|
|
SPYM
1668
PUT
State Street SPDR Portfolio S&P 500 ETF
SPYM
$169B
| $32M | 0.01% |
463,600
+391,400
| +542% | +$27.1M |
|
1669
CALL
Coca-Cola Europacific Partners
CCEP
$47.4B
| $31.9M | 0.01% |
415,800
-141,600
| -25% | -$10.9M |
|
1670
PUT
Vanguard Morningstar Growth ETF
VUG
$230B
| $31.9M | 0.01% |
466,800
+169,200
| +57% | +$11.4M |
|
1671
CALL
Steel Dynamics
STLD
$37B
| $31.9M | 0.01% |
279,700
-10,800
| -4% | -$1.44M |
|
1672
HealthEquity
HQY
$8.79B
| $31.9M | 0.01% |
332,406
+220,451
| +197% | +$20.5M |
|
1673
Principal Financial Group
PFG
$24.5B
| $31.9M | 0.01% |
411,731
+409,696
| +20,132% | +$34.5M |
|
1674
Procore
PCOR
$9.04B
| $31.8M | 0.01% |
424,674
-676,693
| -61% | -$48M |
|
1675
MPLX
MPLX
$60.1B
| $31.8M | 0.01% |
664,563
+647,843
| +3,875% | +$30.1M |
|
Similar funds
Ken Griffin's Q4 2024 Portfolio in Review
As of Q4 2024, Ken Griffin held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.
By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.
- Ken Griffin's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Ken Griffin added most to Boeing in Q4 2024, an estimated $830M increase.
- Ken Griffin's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Ken Griffin fully exited Spotify in Q4 2024, selling an estimated $473M.
- Ken Griffin's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Ken Griffin opened 1,745 new positions and closed 1,423 in Q4 2024.
- Ken Griffin's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.